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ABSTRACT
Quantitative and mechanism-based information on
differences in transfection efficiency between viral
and non-viral vectors would be highly useful for
improving the effectiveness of non-viral vectors.
A previous quantitative comparison of intracellular
trafficking between adenovirus and LipofectAMINE
PLUS (LFN) revealed that the three orders of
magnitude lower transfection efficiency of LFN
was dominantly rate limited by the post-nuclear
delivery process. In the present study, the contribu-
tion of transcription and translation processes to
the overall differences in the transgene expression
efficiency of nucleus-delivered DNA was indepen-
dently evaluated by quantifying mRNA. As a result,
transcription efficiency (Etranscript) of LFN, denoted
as transgene expression divided by the amount of
nuclear pDNA was about 16 times less than that for
adenovirus. Furthermore, translation efficiency
(Etranslate), denoted as transfection activity divided
by mRNA expression was approximately 460
times less in LFN. Imaging of the decondensed
form of DNA by in situ hybridization revealed that
poor decondensation efficiency of LFN is involved
in the inferior Etranscript. Moreover, the inferior
translation efficiency (Etranslate) of LFN was mainly
due to electrostatic interactions between LFN
and mRNA. Collectively, an improvement in nuclear
decondensation and the diminution of the interac-
tion between vector and mRNA is essential for
the development of new generations of non-viral
vectors.
INTRODUCTION
Gene therapy is an ideal concept for curing intractable
diseases. To realize gene therapy, an intelligent vector that
satisﬁes the requirements for both a high transfection
activity and poor cytotoxicity is essential. To date, viral
vectors such as adenovirus and retrovirus have accounted
for more than 70% of the clinical trials (http://www.
wiley.co.uk/genmed/clinical/), mainly because transfec-
tion activities using viral vectors are typically higher
than that of non-viral ones (1,2). However, many clinical
trials in which viral vectors are used have been interrupted
since the application of these vectors induced unexpected
adverse eﬀects such as immunogenicity (3) and oncogeni-
city (4). Based on these drawbacks, the development of
non-viral vectors would be highly desirable.
The most severe bottleneck in the clinical use of a
non-viral vector is its low transfection activity. Therefore,
an improvement of transfection activity is required, if
gene therapy with non-viral vectors is to be required (5).
It is generally accepted that transfection activity is rate
limited by intracellular processes such as cellular uptake,
endosomal escape, nuclear transfer and transcription (6).
Therefore, it would be useful to clarify why and to what
extent the current non-vector is inferior to the viral one
from the point of view of intracellular traﬃcking.
This information would enable us to clearly recognize
which of the barriers need to be overcome for improving
transfection activity, and moreover, to what extent
transfection activity be improved by overcoming each
intracellular barrier.
A novel technique (Confocal Image-assisted Three-
dimensionally Integrated Quantiﬁcation (CIDIQ)) for
quantifying the intracellular distribution of exogenous
DNA based on confocal images (7), has recently
been established. Using this technique, we compared
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LipofectAMINE PLUS (LFN) in cultured cells
(i.e. HeLa and A549 cells), as typical of viral and non-
viral vectors, respectively. Comparing the dose–response
curve, LFN requires 3–4 orders of magnitude more gene
copies to exhibit a transfection activity comparable to the
adenovirus in dividing cells (i.e. A549 cells and HeLa
cells). By measuring nuclear delivery of exogenous DNA,
the contribution of intracellular traﬃcking and subse-
quent post-nuclear events to the overall diﬀerence in
transgene expression could be independently evaluated.
To our surprise, intracellular traﬃcking could not explain
the diﬀerence in transfection eﬃciency. In contrast, the
transfection eﬃciency of nucleus-delivered DNA (TEnuc),
denoted as transfection activity divided by the amount
of nuclear DNA was three orders of magnitude higher
in adenovirus compared with LFN, suggesting that the
post-nuclear delivery process is dominantly responsible
for the diﬀerence in transfection eﬃciency (2). Similar
results have also been reported for other types of non-viral
vectors (i.e. polyplexes) (8).
Although, in a previous study, we reported that TEnuc
was attributed to the nuclear transcription process (2),
the transgene expression of nucleus-delivered DNA is
ruled by central dogmas, consisting of transcription and
translation processes. In the present study, the contribu-
tions of these two processes to the overall diﬀerences in
TEnuc were quantitatively evaluated by measuring the
amount of cellular mRNA, an intermediate component
of the central dogma. Furthermore, mechanisms under-
lying the diﬀerence in each process were clariﬁed.
These studies could serve as a guideline for future studies
of non-viral gene vectors, since clear answers were
found in this article concerning the problem of current
non-viral vectors.
MATERIALS AND METHODS
Materials
HeLa cells were obtained from the RIKEN Cell Bank
(Tsukuba, Japan). To prepare the reporter gene vector
encoding luciferase (GL3) and EGFP (pcDNA3.1-lucifer-
ase and pcDNA3.1-EGFP), cDNA fragment encoding
these proteins were inserted into the pcDNA3.1
(Invitrogen, Carlsbad, CA, USA) respectively, as reported
earlier (2,9). LFN reagents were purchased from
Invitrogen (Carlsbad, CA, USA). The E 
1 ,E  
3 , replica-
tion-deﬁcient serotype 5 adenovirus was used in the
adenoviral vector, in which an expression cassette
is inserted at the E1 position (10).
Quantification of intracellular and intranuclear mRNA
Transfection was performed following the manufacturer’s
instructions, as described earlier (11). Brieﬂy, 15mlo f
PLUS reagent was mixed with 482.5ml of DMEM
containing 2.5mg of plasmid DNA (pDNA), without
serum and antibiotics (DMEM( )), and incubated
for 15min at room temperature. About 10mlo f
aliquot of LipofectAMINE was suspended with 490ml
of DMEM( ). The LipofectAMINE suspension was
then added to the PLUS–pDNA mixture, and further
incubated for 15min at room temperature. Samples
containing 2.5mg of pDNA suspended in 1ml of
DMEM( ) were added to 2.5 10
5 cells and incubated
for 3h at 378C. The time when pDNA was applied to the
cells is deﬁned as time zero.
Total RNA was extracted from whole cell and isolated
nuclei with an RNeasy Mini Kit with RNase-Free DNase
Set (QIAGEN, Tokyo, Japan). Isolated nuclei were
prepared from the suspension of the cells in lysis solution
(0.5% IGEPAL CA630, 10mM NaCl, 3mM MgCl2 and
10mM Tris-HCl, pH 7.4), followed by centrifugation at
9200 g for 2min at 48C, as described earlier (11,12).
Since nuclei can be separated during the centrifugation,
the most likely contaminants would be mitochondria.
A western blot analysis for the cytochrome c, a marker
protein for mitochondria, conﬁrmed that very few (less
than 7%) mitochondria were present in the nuclear
fraction as contaminants (data not shown). Reverse
transcription was performed using an ExScript RT
reagent Kit by oligo-dT primer (TAKARA, Siga,
Japan), and the cDNA product encoding luciferase was
then quantiﬁed by RealTime PCR with the sets of primer
listed in Table 1. As a standard, a dilution series of cDNA
synthesized from the known amount of luciferase
mRNA (Promega, Tokyo, Japan) was used. To determine
the amount of mRNA per cell, the amount of mRNA
puriﬁed from whole cells was normalized by the number
of cells estimated from the amount of b-actin mRNA.
A linear relationship was conﬁrmed between the
numbers of cells and the amount of total cellular
mRNA of b-actin. The sequences of primers used in the
quantiﬁcation of cDNA encoding b-actin are summarized
in Table 1.
Similarly, the amount of luciferase mRNA in the
isolated nuclei was normalized by the cell number.
In order to determine cell number based on the amount
of nuclear b-actin mRNA, it must be converted to the
amount of total cellular b-actin mRNA that is linearly
related to cell number. Therefore, the nuclear fraction
of b-actin mRNA to that in the whole cell (Fnuc, b-act) was
preliminarily determined as b-actin mRNA in the isolated
nuclear fraction, divided by b-actin mRNA in the whole
cell. As a result, Fnuc, b-act was calculated to be 0.033.
In each sample, for the measurement of mRNA in an
isolated nucleus, b-actin mRNA was also measured,
and was then, divided by Fnuc, b-act to convert to total
cellular b-actin mRNA that can be used to determine cell
number.
Influence of adenovirus core proteins on transcription
To pre-load the adenovirus core proteins in the nucleus,
host cells were pre-infected with adenovirus encoding
EGFP for 1, 3 and 6h at 378C. Subsequently, pDNA
encoding luciferase was transfected with LFN. After an
additional incubation for 6h at 378C, cells were
collected, and a luciferase assay was performed as
reported earlier (11).
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The adenovirus genome was puriﬁed as reported earlier
with minor modiﬁcations (13). Adenovirus, encoding
EGFP (1 10
12 particles) was dialyzed with TE buﬀer
(10mM Tris, 1mM EDTA, pH 8.0). The adenovirus
solution was then treated with an equal volume of 8M
guanidine and incubated for 5min at 48C on ice. After
a 5–20% sucrose gradient ultracentrifugation (SW41Ti,
30000rpm, 48C, 16h), a 0.5ml aliquot was collected from
the bottom. To identify the adenovirus genome fraction,
each fraction was incubated with 1mg/ml of Hoechst33342
and the ﬂuorescence was then measured.
The concentration of adenoviral genomic DNA and
pDNA encoding EGFP was determined by RealTime
PCR, as described earlier, using the set of primers shown
in Table 1. Adenoviral genomic DNA and pDNA
encoding EGFP was injected at a dose of 10 copies/
nucleus with 0.5% of rhodamine-labeled dextran
(RhoDex: M.W. 70000) as an injection marker (9).
At 24h post-injection, EGFP expression was monitored
by ﬂuorescence microscopy, and the ratio of cells
expressing EGFP to those injected with rhodamine-
labeled dextran was calculated.
Fluorescence in situ hybridization (FISH) combined
withtyramide signal amplification (TSA)
To address the decondensation process, intranuclear
DNA was visualized by in situ hybridization. Concerning
the probes for the detection of pDNA introduced by LFN,
two regions (3076-3732, 3996-4525) in pcDNA 3.1 (þ)
were ampliﬁed by PCR with the primers shown in Table 1,
and were then biotinylated using a Label IT Nucleoic Acid
Modifying Kit (TAKARA, Siga, Japan). Concerning the
probe for the detection of the adenovirus genome,
Adenovirus Bioprobe (Enzo, NY, USA) was used. Cells
were seeded in 0.002% poly-L-lysine-coated LabTek II
chamber slides. After adenovirus- or LFN-mediated
transfection for 10h, the samples were washed with PBS
and ﬁxed with 4% paraformaldehyde/PBS. To activate
the hybridization, the sample was treated with 5mg/ml
of Proteinase K for 15min at room temperature.
After washing with PBS, the sample was subjected to
a 0.3% H2O2/methanol treatment for 20min at room
temperature to inactivate endogenous peroxidases.
0.5–1mg/ml of each probe in hybridization buﬀer (50%
formamid, 5  SSC, 5  Denhardts, 250mg/ml Bakers
yeast RNA, 500mg/ml herring sperm DNA) was applied,
and the sample was then denatured for 5min at 958C.
After incubation overnight at 378C, non-reactive probe
was removed by incubation in 0.2  SSC for 20min and
0.1  SSC for 10min at 428C. Hybridization signals were
ampliﬁed with a TSA Biotin system (PerkinElmer, Tokyo,
Japan) following the manufacturer’s instructions.
The signal was ﬁnally visualized with 10mg/ml TexasRed
labeled streptavidin (Molecular Probes, Eugene, OR,
USA) and observed by confocal laser scanning micro-
scopy (Carl Zeiss Co. Ltd., Jena, Germany).
Investigation ofthe interaction between mRNA
andvectors by RealTime RT-PCR
To evaluate the interaction of adenovirus and LFN
to mRNA, luciferase-encoding mRNA was subjected to
reverse transcription with adenovirus and LFN encoding
EGFP. If the vector strongly interacts with mRNA,
reverse transcription must be inhibited. Applied adeno-
virus and LFN was removed by means of a GenElute
Mammalian Genome DNA Miniprep kit, and the cDNA
product was then quantiﬁed by RealTime PCR as
described above.
Invitro translation
Adenovirus or LFN was incubated with luciferase mRNA
at a concentration of 72 copies/pl for 10min on ice.
An in vitro translation was performed using a Rabbit
Reticulocyte Lysate System (Promega, Tokyo, Japan) as
described in the manufacturer’s instructions. The amount
Table 1. Sequences of primers and probes used in this study
A. Quantiﬁcation of gene copies of pDNA and cDNA for luciferase
Luc (þ) primer 50-TTGACCGCCTGAAGTCTCTGA-30
Luc ( ) primer 50-ACACCTGCGTCGAAGATGTTG-30
TaqMan probe 50-FAM-CCGCTGAATTGGAATCCATCTTGCTC-TAMRA-30
B. Quantiﬁcation of genomic DNA of b-actin
b-actin (þ) primer 50-TGCGTGACATTAAGGAGAAGCTGTG-30
b-actin ( ) primer 50-CAGCGGAACCGCTCATTGCCAATGG-30
C. Quantiﬁcation of gene copies of pDNA for EGFP
EGFP (þ) primer 50-TCGAGCTGGACGGCGACGTA-30
EGFP ( ) primer 50-GCTGAAGCACTGCACGCCGT-30
D. Preparation of probes used in in situ hybridization of pDNA
3076-3732 (þ) primer 50-TCTCATGCTGGAGTTCTTCG-30
3076-3732 ( ) primer 50-CTCTGACTTGAGCGTCGATT-30
3996-4525 (þ) primer 50-CGGTAAGACACGACTTATCG-30
3996-4525 ( ) primer 50-CGTAGTTATCTACACGACGG-30
The Luc primers were used for quantifying intranuclear and intracellular mRNA and intranuclear DNA. The TaqMan probe with FAM as a
ﬂuorescent dye on the 50 end and TAMRA as a ﬂuorescence quencher dye labeled to the 30 end is designed to anneal to the target between Luc (þ)
and Luc ( ) as described in the upper panels. The b-actin primers were used to correct the number of cells. The EGFP primers were used for the
quantiﬁcation of the copy number of EGFP DNA. The 3076-3732 primers and 3996-4525 primers were used in the preparation of the probe for in
situ hybridization.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1535of synthesized protein was determined by a luciferase
assay as reported earlier (11).
RESULTS
Systematiccomparison of transcription efficiency
andtranslation efficiency between adenovirus-
andLFN-mediated transgeneexpression
An earlier analysis indicated that the TEnuc of LFN was
7000 times less than that of adenovirus in HeLa cells (2).
These data indicate that post-nuclear events, but not
intracellular traﬃcking, are the dominant factors respon-
sible for the 3–4 orders of magnitude lower transgene
expression eﬃciency in LFN. To evaluate the contribution
of translation and transcription processes to overall TEnuc,
the expression level of mRNA was quantiﬁed by RealTime
RT-PCR at 3h post-transfection. Under conditions where
transgene expression was comparable, LFN exhibited
an approximately 270 times higher mRNA expression
than adenovirus (Table 2). Furthermore, it was demon-
strated that the number of nuclear pDNA transfected
by LFN was approximately 4000-fold more than that for
adenovirus (approximately 1.7 10
4 copies/cell versus 4.1
copies/cell) (2). Transcription eﬃciency (Etranscript) was
calculated as the number of copies of cellular mRNA
divided by the nuclear amount of DNA. As a result, the
Etranscript value for adenovirus was approximately 16 times
higher than that for LFN (Table 2 and Figure 1).
Similarly, we can calculate the translation eﬃciency
(Etranslate), as transgene expression divided by the number
of copies of mRNA. As a result, adenovirus represented
460 times higher eﬃciency compared with LFN (Table 2
and Figure 1).
Contributionof theadenovirus-derived factorsto the
differenceof transcriptional efficiency between
adenovirus and LFN
To utilize this quantitative information in developing
a new-generation artiﬁcial vector, it is essential to clarify
the mechanism underlying the large diﬀerences in
Etranscript and Etranslate between adenovirus and LFN.
Concerning the transcription process, two hypotheses
were postulated, based on the assumption that activation
factors exist in the adenoviral vector. One is that
adenoviral core proteins delivered to the nucleus with
genomic DNA may activate nuclear transcription factors.
The other is that the genome structure and/or sequence
derived from adenovirus were advantageous for transcrip-
tion. In the present study, the sequences of a cytomegalo-
virus promoter/enhancer, cDNA-encoding luciferase and
BGH polyadenylation used were the same between
adenovirus and pDNA. However, it is possible that
a unique sequence and/or linear structure in adenovirus
may confer advantages to nuclear transcription.
To address the contribution of the core proteins to the
diﬀerence of Etranscript, they were pre-loaded to the nucleus
beforehand by the infection of EGFP-encoding adeno-
virus. Subsequently, the pDNA-encoding luciferase was
transfected with LFN. If core proteins activate nuclear
transcription activity, luciferase expression of lipoplex
should be improved by pre-infection with the adenovirus.
However, as shown in Figure 2, the transfection activity
remained essentially unchanged, compared with that in
non-treatment (open bar) regardless of the pre-infection
time (1, 3 and 6h) or the dose (500–50000 particles/cell).
Unexpectedly, the transfection activity tended to decrease
depending on the dose of adenovirus, presumably because
of the cytotoxicity of adenovirus. This suggests that
contributions of adenoviral core proteins to the diﬀerence
in transcription activity are minor.
The involvement of unique genome structure and/or
sequence in adenovirus in the diﬀerence of transcription
eﬃciency was then investigated by the nuclear micro-
injection of adenovirus genomic DNA and pDNA
encoding EGFP at a dose of 10 copies/nucleus. RhoDex
was simultaneously injected as an injection marker.
Table 2. Quantitative comparison of transcription and post-
transcription eﬃciency between Ad and LFN
Ad LFN
Nuclear DNA (copies/cell)
1 4.1 1.7 10
4
Cellular mRNA (copies/cell) 1.6 10
4 4.3 10
6
Transgene expression
(RLU/mg protein)
1
2.3 10
7 1.3 10
7
Transcription eﬃciency (Etranslate)
(cellular mRNA/nuclear DNA)
4.0 10
3 2.5 10
2
Post-transcription eﬃciency (Etranscript)
(transgene expression/cellular mRNA)
1.4 10
3 3.0
Nuclear DNA and transgene expression was quantiﬁed after adeno-
virus- and LFN-mediated transfection at 1h, and 3h, respectively.
Cellular mRNA was quantiﬁed by RealTime RT-PCR after transfec-
tion for 3h. Transcription eﬃciency was calculated as cellular mRNA
divided by nuclear DNA. Post-transcription eﬃciency was calculated
as the transgene expression divided by the cellular mRNA.
1The amount of nuclear DNA (copies/cell) and transgene expression
(RLU/mg protein) are cited from reference (2).
Nucleus
DNA
mRNA
Protein
Ad > LFN
7000-fold
mRNA
Translation
efficiency
(Etranslate)
Ad > LFN
460-fold
Transcription
efficiency
(Etranscript)
Ad > LFN
16-fold
Transfection
efficiency of
nuclear DNA
(TEnuc)
Figure 1. Summary of the contribution of the transcription and
translation processes to the overall transgene expression eﬃciency of
nuclear DNA (TEnuc). The TEnuc for adenovirus was approximately
7000 times higher compared to that for LFN. By measuring the amount
of cellular mRNA, an intermediate component of the central dogma,
contributions of the diﬀerences in the transcription process and the
translation process to the overall diﬀerence in TEnuc were quantitatively
evaluated. In the transcription process, LFN was 16 times less eﬃcient.
In post-transcriptional processes, the translation eﬃciency of adeno-
virus was 460 times more eﬃcient.
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EGFP was evaluated as the number of EGFP-expressing
cells divided by the number of RhoDex-positive cells.
As a result, the expression eﬃciency of the adenovirus
genome was not signiﬁcantly diﬀerent from that of pDNA
(35 9.8% versus 25 3.7%) (Figure 3), suggesting that
genomic structures or sequences derived from adenovirus
are not involved in the high transcription eﬃciency
of adenovirus. These data collectively indicate that an
adenovirus-derived structure and/or sequence were not
a dominant factor in the observed diﬀerence in Etranscript.
Comparison of thenuclear disposition of adenoviral
genomicDNA andpDNA
The results obtained exclude the activation hypothesis
by adenovirus-derived factors. Therefore, the nuclear
disposition of adenoviral genomic DNA and pDNA was
compared from two points of view. One is the diﬀerence of
decondensation eﬃciency. To improve cellular uptake and
the regulation of intracellular traﬃcking of DNA, it is
generally condensed with a cationic polymer or liposomes.
However, once inside the nucleus, it must be released from
the vectors to be recognized by transcription factors.
Therefore, it is possible that the low transcription
eﬃciency of LFN is due to the ineﬃcient dissociation
of pDNA from cationic liposomes. The other concern is
subnuclear localization. It is generally accepted that
nuclear transcription activity is rich in the euchromatin
region, and that inactivated DNA is stored in the
heterochromatin region. Therefore, it is possible that
diﬀerences in the localization of DNA in the nucleus could
contribute to the diﬀerence in Etranscript.
To investigate the diﬀerence in decondensation
eﬃciency, the decondensed form of pDNA was visualized.
When an alkaline phosphatase-labeled oligonucleotide
(ODN) probe was hybridized with naked pDNA and the
lipoplex blotted onto a nylon membrane, a clear signal
was detected only in naked DNA (Supplementary
Figure 1A and B), presumably because interactions
between pDNA and probe were prevented by LFN via
steric hindrance caused by condensation. This result
strongly indicates that the detection of DNA based on
the hybridization technique is useful for speciﬁcally
visualizing the released form of DNA. Therefore, nuclear
DNA released from the vector was visualized by in situ
hybridization at 10h after transfection with adenovirus
and LFN. To detect nuclear DNA with high sensitivity,
a TSA was applied. As a result, a remarkable number
of signals were detected in the adenoviral genomic DNA
(Figure 4A), whereas only a few pDNA molecules were
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Figure 3. Comparison of transgene expression after the nuclear
microinjection of adenoviral genomic DNA and pDNA. Adenovirus
genomic DNA was puriﬁed by a guanidine treatment, followed
by sucrose density gradient centrifugation. After quantiﬁcation of
the concentration of genome DNA and pDNA by RealTime PCR,
genomic DNA and pDNA was microinjected into the nucleus at a
dose of 10 copies/nucleus with rhodamine-labeled dextran (Rho-Dex)
as an injection marker. At 24h post-microinjection, EGFP expression
eﬃciency was evaluated.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1537detected in LFN (Figure 4B). Under this condition, the
nuclear delivery of pDNA was approximately 700 times
higher than adenoviral genomic DNA when quantiﬁed by
TaqMan PCR (Figure 4C). To compare hybridization
eﬃciency between adenoviral genomic DNA and pDNA,
known amounts of puriﬁed genomic DNA or pDNA were
blotted on a nylon membrane at various dilutions,
and detected by a TSA system with probes used in the
in situ hybridization (Supplementary Figure 1C and D).
The intensity of each signal was quantiﬁed by means of
a Scion Image and plotted against the number of gene
copies blotted. As a result, the slope of the regression line
for the adenoviral genomic DNA was only slightly higher
(less than approximately 5-fold higher in adenovirus),
suggesting that a signiﬁcantly higher detection of nuclear
genomic DNA cannot be accounted for by a diﬀerence
in hybridization eﬃciency. These data indicate that poor
decondensation of pDNA is one of the major reasons
for the decreased Etranscript of LFN.
The subnuclear localization of adenoviral genomic
DNA and LFN was further investigated. Nuclear staining
with DAPI can be used to classify the intranuclear space
into two regions. One was a strongly stained region, in
which genomic DNA is concentrated (heterochromatin),
and the other is poorly stained region, in which genomic
DNA is less concentrated (euchromatin). Dual imaging
of free-form DNA and DAPI staining indicated that all
of the adenoviral genomic DNA was speciﬁcally located
in the euchromatin region. In contrast, pDNA was
detected in both regions (Figure 5). Therefore, adenovirus
can deliver its genomic DNA to the euchromatin
region speciﬁcally, where transcription activity is higher.
These data collectively indicate that diﬀerences in nuclear
disposition such as decondensation or subnuclear locali-
zation are possible mechanisms for the diﬀerence in
Etranscript.
Investigation of themechanism forthe different
translation efficiency between adenovirus andLFN
The mechanism for the diﬀerences in Etranslate was
investigated. Considering that RNA, is a negatively
charged molecule, like DNA, it is highly possible that
LFN may interact with mRNA via electrostatic interac-
tions. To address this issue, we ﬁrst compared the
interaction of LFN and adenovirus with mRNA by
monitoring the inhibitory eﬀect on the reverse transcrip-
tion of mRNA. Luciferase-encoding mRNA was subjected
to reverse transcription with or without adenovirus
particles and LFN encoding EGFP. The cDNA product
for luciferase was puriﬁed, and then quantiﬁed by
RealTime PCR. cDNA production was decreased slightly
in adenovirus (Figure 6A), whereas it was dramatically
decreased in LFN (Figure 6B). When 3 10
9 copies of
adenovirus and LFN were applied, cDNA production
was decreased by 20 and 90%, respectively, compared
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Figure 4. Detection of the free form of adenoviral genomic DNA and
pDNA by in situ hybridization. After 10h post-transfection with
adenovirus (A) or LFN (B) at a dose of 20 copies/cell and 3.4 10
6
copies/cell, the decondensed form of DNA was detected by in situ
hybridization with TSA system. (C) Quantitative comparison of nuclear
DNA between adenovirus and LFN. After 10h post-transfection with
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Figure 5. Comparison of nuclear sublocalization between the
adenovirus genome and pDNA. At 10h post-transfection with Ad
(20 copies/cell) or LFN (3.4 10
6 copies/cell), nuclear adenoviral
genomic (A) or pDNA (B) was detected by in situ hybridization (red).
Cell nuclei were stained by DAPI (blue).
1538 Nucleic Acids Research, 2007, Vol. 35, No. 5with the non-treatment. These results suggest that LFN
interacts with RNA more intensively than adenovirus.
Based on these observations, two hypotheses can
be postulated to explain the diﬀerence in translation
eﬃciency. One is that LFN may entrap mRNA in the
nucleus and perturb its nuclear export. The other is that
the recognition of cytoplasmic mRNA by ribosomal RNA
or translation-related protein is inhibited.
The nuclear distribution of mRNA was then compared
for adenovirus- and LFN-mediated transfection. Three
hours after the transfection, cellular and intra-nuclear
mRNA was quantiﬁed by RealTime RT-PCR (Table 3).
The fraction of nuclear mRNA (Fnuc, mRNA), denoted as
the nuclear amount of mRNA divided by total cellular
mRNA was comparable between adenovirus and LFN
(approximately 5.8 and 6.3%, respectively), suggesting
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Figure 6. Eﬀect of adenovirus and LFN on the post-transcription process. (A, B) Interaction between mRNA and vectors. Adenovirus (A) or LFN
(B), encoding EGFP was applied to a reverse transcription reaction using a luciferase mRNA (8.5 10
9 copies/reaction). The cDNA product was
quantiﬁed by RealTime PCR. (C, D) The inﬂuence of adenovirus and LFN on an in vitro translation system. About 4.3 10
8 copies/reaction
of mRNA encoding luciferase was subjected to the in vitro translation with or without adenovirus (C) or LFN (D), at a dose of 6.8 10
9
copies/reaction. Protein synthesis was quantiﬁed by a luciferase assay. (E) Inﬂuence of adenovirus and LFN on the luciferase expression stably
expressed in the HeLa cells. At 10h post-transfection with Ad or LFN at the indicated doses, transgene expression was determined by a luciferase
assay. Data are represented as the percent of untreated cells. These data represent the mean values and standard deviation for triplicate experiments.
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do not inhibit the nuclear export process of mRNA.
To investigate the eﬀect of vectors on the cytoplasmic
translation process, mRNA encoding luciferase was
subjected to in vitro translation with or without adeno-
virus and LFN. When adenovirus was applied to an
in vitro translation system, approximately 20% of the
protein synthesis was inhibited compared with non-
treatment (Figure 6C). On the other hand, when LFN
was added to this system, protein synthesis was drastically
inhibited to less than 90% (Figure 6D). To conﬁrm the
inhibitory eﬀect of LFN on translation process by
a whole-cell system, HeLa cells stably expressing luciferase
were incubated with adenovirus or LFN encoding EGFP.
Luciferase activity was not aﬀected by the adenovirus
infection after 10h, regardless of the dose (Figure 6E).
In contrast, luciferase activity was decreased by incuba-
tion with LFN in a dose-dependent manner. It is note-
worthy that the inhibitory eﬀect was signiﬁcant, even
when a conventional dose (1.5 10
6 copies/cell) of LFN
was applied to the cells (to 60%). Collectively, these data
indicate that the inhibition of the translation process
via electrostatic interactions of LFN and mRNA is clearly
a factor in the diﬀerence in Etranslate between LFN and
adenovirus.
DISCUSSION
For the development of a non-viral vector, the intra-
cellular and intranuclear disposition of exogenous DNA
must be rigorously regulated. To date, many eﬀorts have
been made to develop devices for overcoming intracellular
barriers from the standpoint of strategy of viral vectors.
However, in the majority of the studies, only the
enhancement in transfection activity before and after the
modiﬁcation of the devices has been used as the deﬁnition
of success, and the quantitative evaluation of intracellular
traﬃcking has rarely been demonstrated. As a result,
it is diﬃcult to predict which of the intracellular barriers
need to be improved in order to further enhance
the transfection activity. Many researchers have accepted
these trial-and-error approaches in the past, mainly
because an appropriate methodology for evaluating the
intracellular traﬃcking of pDNA was not available.
We recently quantiﬁed the nuclear delivery of DNA
transfected by adenovirus and LFN that enabled us to
recognize the contribution of intracellular traﬃcking
(intracellular pharmacokinetics: iPK) and post-nuclear
events (pharmacodynamics: PD) to the overall diﬀerence
in transfection eﬃciency between adenovirus and LFN.
As a result, the TEnuc for adenovirus, calculated as
transgene expression divided by the number of gene copies
in the nucleus, was approximately 7000 times higher than
that of LFN, suggesting that the diﬀerence in PD is a
dominant factor in the diﬀerence in transfection activity.
We reported earlier that this large diﬀerence was derived
from the diﬀerence of transcription process (2). However,
post-nuclear process is comprised of the transcription and
translation. Therefore, the mechanism underlying the
diﬀerence in TEnuc was further investigated by measuring
mRNA expression, an intermediate of central dogma. As
a result, a three orders of magnitude diﬀerence in TEnuc
was found to be attributed to the one order of magnitude
diﬀerence in transcription process and to the two orders of
magnitude diﬀerence in the translation process, as shown
in Figure 1.
To relate the above quantitative information to
the development of a non-viral vector, the mechanism
underlying these diﬀerences was further investigated.
Concerning the diﬀerence in the transcription process,
four hypotheses were formulated. The ﬁrst two are based
on the assumption that speciﬁc activators are present in
the adenovirus. One is a core protein that enters the
nucleus with adenoviral genomic DNA and activates
a nuclear transcription factor. The other is that a unique
sequence or the structure of genomic DNA may be
advantageous for the transcription process. The latter two
hypotheses are based on the assumption that the nuclear
disposition of pDNA introduced by a non-viral vector
is inappropriate for the transcription. For example,
the poor decondensation of pDNA in the nucleus may
prevent transcription factors from recognizing the
promoter region. Alternatively, the nuclear distribution
of pDNA could be inappropriate for the nuclear
transcription. In the present study, we clariﬁed which
hypothesis is plausible for accounting for the diﬀerence
in intranuclear transcription eﬃciency.
Concerning the inﬂuence of adenovirus core proteins
on transcription, various types of basic proteins, such as
protein VII, mu and protein V have been reported
as condensers of adenovirus DNA via electrostatic
interactions. Non-viral vectors prepared with core
proteins as a condenser of pDNA have been developed
(14,15). Although it has been reported that a vector
promotes the eﬃcient delivery of exogenous gene to the
nucleus, its role in transcription event has not been
clariﬁed. It has been demonstrated that terminal proteins,
protein V, protein VII and mu (16) interact with nuclear
subdomains (i.e. PML body, nucleoli and the nuclear
matrix) (17–19). In particular, protein V releases
nucleophosmin/B23 from nucleoli. Since the B23 is a
chromatin-remodeling factor, which promotes transcrip-
tion activity by loosening the chromatin structure of
the transcriptional region, it may facilitate the transcrip-
tional factor to gain access to the genome (20). However,
as shown in Figure 2, the transfection activity of LFN
was not stimulated by pre-incubation with adenovirus,
Table 3. Quantitative comparison of the nuclear export of mRNA
between Ad and LFN
Adenovirus LFN
Nuclear mRNA (copies/cell) 9.3 10
2 2.7 10
5
Cellular mRNA (copies/cell) 1.6 10
4 4.3 10
6
Nuclear fraction (Fnuc, mRNA)
(%: nuclear mRNA/cellular mRNA)
5.8 6.3
Numbers of nuclear mRNA in Ad- and LFN-mediated transfection
were quantiﬁed by nuclear isolation, followed by RealTime PT-PCR.
The nuclear fraction of mRNA was calculated as nuclear mRNA
divided by cellular mRNA.
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diﬀerence in transcription eﬃciency was minor. This is
consistent with the fact that transgene expression of the
mu–pDNA complex does not represent a signiﬁcantly
higher transgene expression compared with the poly-
L-lysine–pDNA complex (14). The involvement of
a structure or sequence in the adenovirus genome was
then evaluated. The expression cassette (i.e. cytomegalo-
virus promoter/enhancer, cDNA encoding luciferase and
BGH polyadenylation) used in the present study was
completely identical between adenovirus and pDNA.
However, it is possible that a unique sequence and/or
linear structure in adenovirus may confer advantages
to nuclear transcription. It has been demonstrated that
50-terminal protein is associated with transcriptional
factor Oct-1, followed by recruiting the transcriptional
complex on the TATA box (21,22). Furthermore,
a consensus sequence is present in ITR (23) for the
binding of transcription factors (e.g. SP1, ATF) which
may promote the downstream CMV promoter. However,
the results of microinjection experiments showed that
the adenovirus genome showed only a slightly higher
transcription eﬃciency than pDNA. Thus, a diﬀerence in
the structure and sequence cannot explain the diﬀerence
in transcript eﬃciency.
Since the diﬀerence in transcriptional eﬃciency cannot
be accounted for based on the hypothesis that activation
factors exist in adenovirus, the mechanism was investi-
gated with reference to another hypothesis; the nuclear
disposition of pDNA was disadvantageous for transcrip-
tion. One possible diﬀerence in the nuclear disposition
of DNA is its decondensation proﬁle. Therefore,
a decondensed form of adenoviral genomic DNA and
pDNA, was detected by in situ hybridization. The selective
detection of the decondensed form of DNA by a
hybridization technique was conﬁrmed by dot blotting
(Supplementary Figure 1A and B). As a result, adenoviral
genomic DNA was more intensively detected in the
nucleus compared to pDNA, even though the total
nuclear association of pDNA in the LFN-mediated
transfection was 700 times higher than that of adenovirus.
These data indicate that nuclear decondensation eﬃciency
in LFN was much less prominent compared to adeno-
virus. Since transgene expression after nuclear microinjec-
tion was not enhanced by changing the condensing
counterpart from poly-L-lysine to mu (14), other adeno-
viral core proteins may be responsible for the eﬃcient
decondensation in nucleus. It has been reported that the
chromatin-like structure of adenoviral genomic DNA,
formed with protein VII is released by the nuclear histone
chaperon, TAF (24–26). In addition, it is known that
protein VII possesses a domain, that is subject to
acetylation (27). Considering that adenovirus-mediated
transgene expression is increased by histone deacetylase
inhibitors (28,29), the interaction between protein VII
and DNA may be epigenetically attenuated. Collectively,
adenovirus may achieve eﬃcient decondensation by
remodeling as a the result of TAF and/or epigenetic
regulation (e.g. acetylation of protein VII). Moreover, the
poor decondensation in LFN was consistent with previous
microinjection studies showing that the transgene
expression of pDNA after nuclear microinjection was
greatly inhibited compared with the microinjection of
lipoplex (30,31). The driving force for the decondensation
process in a lipoplex has not been clariﬁed to date. We
recently found that only a part of the nuclear pDNA-
positive cell exhibited transgene expression, suggesting
that heterogeneity in the nuclear transcription process is
involved in the overall heterogeneity in transgene expres-
sion on LFN. In addition, the transcription eﬃciency was
enhanced at the late S phase, where basic proteins such as
histones are synthesized in conjunction with DNA
synthesis (32). Therefore, the nuclear accumulation
of histones may induce the decondensation of pDNA
by replacing the counterpart cationic liposomes with
histone itself. Therefore, condensation between LFN and
pDNA is too tight to allow it to decondense in the
nucleus, when the synthesis of histones is insuﬃcient. The
development of a decondensation system regardless of the
cell cycle may improve the transcription eﬃciency of non-
viral vectors.
It has recently been reported that the transfection
activity of adenovirus in airway epithelial cells, in which
adenoviral receptors are lacking, was drastically induced
with the aid of cationic liposomes (33). This successful
gene expression was synergistically achieved by the
function of a cationic liposome (as a regulator of cellular
uptake and subsequent intracellular traﬃcking), and the
function of adenovirus (as a regulator of intranuclear
disposition). Therefore, a combination of cationic lipo-
somes and the adenoviral vector may be one of the elegant
solutions for improving transfection eﬃciency.
Regarding subnuclear localization, all of the decon-
densed adenovirus was detected in the regions that are not
intensively stained by DAPI, suggesting that the adeno-
virus genome accumulated eﬃciently to the euchromatin.
MAR in the ITR sequence in adenoviral genomic DNA
may anchor it to the nuclear matrix region (34–36).
Concerning non-viral vectors, pDNA condensed with
protamine exhibited a higher transcription eﬃciency
compared with other cationic polymers (9). Considering
the fact that protamine contains MAR in its sequence
(37), the regulation of subnuclear localization of pDNA
by a MAR-associating signal would result in an improved
transcription eﬃciency. Alternatively, it is possible that
the diﬀerence in subnuclear localization may be derived
from a diﬀerence in the nuclear entry pathway (NPC-
dependent versus NPC-independent pathway). Taking the
size of lipoplex (4200nm) into consideration, pDNA
may enter the nucleus via a nuclear pore complex
(NPC)-independent mechanism such as membrane fusion
(38) since the NPC cannot accept macromolecules with
a diameter of 439nm. Therefore, DNA entering via
the NPC may be more eﬃciently accessible to the
euchromatin region.
Concerning the translation eﬃciency, LFN requires two
orders of magnitude more mRNA to produce a transgene
expression comparable to adenovirus. Since LFN and
adenovirus are positively and negatively charged, respec-
tively (39), electrostatic interactions of each vector
and mRNA should be diﬀerent. In fact, LFN inhibited
the reverse transcription, while adenovirus rarely
Nucleic Acids Research, 2007, Vol. 35, No. 5 1541inhibited (Figure 6A and B). Based on this result, it would
be expected that the nuclear export process, along
with cytoplasmic translation may be strongly inhibited
in LFN. However, this did not hold true. As shown in
Table 3, the nuclear fraction of mRNA (Fnuc, mRNA)
was comparable between adenovirus and LFN (Table 3).
Recent studies have indicated that the formation of
an exon-junction complex (EJC), is related to the
transcription process (40–42), and subsequent export
from the nucleus with the function of the nuclear export
factor (TAP). Since these processes were coupled to
each other, LFN would have no opportunity to bind
to nuclear mRNA. Alternatively, LFN cannot recognize
nuclear mRNA, since the intranuclear environment
is rich in negatively charged molecules such as
genomic DNA.
Finally, the inhibitory eﬀect of adenovirus and LFN on
in vitro translation was compared. In the present study,
LFN severely inhibited in vitro translation by 95% at a
concentration of 2.7 10
2 copies/pl, while adenovirus
only slightly inhibited this process (Figure 6C and D).
To quantify the intracellular traﬃcking of pDNA,
1.4 10
6 copies/cell of pDNA was applied. In this
condition, 8.0 10
4 copies/cell of pDNA were taken up
by the cells. Based on the assumption that the intracellular
volume is 4pl, the intracellular concentration was
calculated to be approximately 2 10
4 copies/pl.
This concentration is much higher than that used in the
in vitro translation study. Therefore, it is plausible that
LFN associates with mRNA and inhibits the translation
process in living cells. Actually, the incubation of LFN
inhibited the stably expressed marker genes (Figure 6E).
In summary, we succeeded in independently quantifying
the contribution of the transcription and translation
processes to the overall diﬀerences in the transgene
expression eﬃciency of nuclear-delivered DNA. In addi-
tion, the mechanism underlying the diﬀerence in each
process was clariﬁed. As a result, the transcription
eﬃciency of LFN was found to be 16 times less eﬃcient
than adenovirus presumably due to poor decondensation
and non-selective subnuclear localization. Furthermore,
the translation eﬃciency was approximately 460 times less
in LFN, mainly due to the strong interactions between
LFN and mRNA in the cytoplasm. However, these results
do not exclude the importance of the regulation of
intracellular pharmacokinetics. Intracellular traﬃcking
and intranuclear transcription are connected in tandem.
Therefore, if intracellular traﬃcking was barely regulated,
transfection activity must also be poor. It should be noted
that a dividing cell line (HeLa) was used in the present
analysis. Therefore, in the case of non-dividing cells (i.e.
primary cells), nuclear delivery must still be a severe
barrier to a successful gene delivery system. Collectively,
we conclude that the regulation of post-nuclear processes
(improvement of intranuclear decondensation and the
avoidance of electrostatic interactions between the vector
and mRNA), along with intracellular traﬃcking is
essential for developing a new generation of non-viral
vector, which represents a transfection activity compar-
able to adenovirus.
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